nodes	percent_of_prediction	percent_of_DWPC	metapath
Bimatoprost—AKR1C3—Doxorubicin—kidney cancer	0.47	1	CbGbCtD
Bimatoprost—PTGER1—renal system—kidney cancer	0.00534	0.186	CbGeAlD
Bimatoprost—PTGER1—kidney—kidney cancer	0.00517	0.18	CbGeAlD
Bimatoprost—AKR1C3—Vincristine—Vinblastine—kidney cancer	0.00479	0.554	CbGdCrCtD
Bimatoprost—PTGER3—renal system—kidney cancer	0.00469	0.163	CbGeAlD
Bimatoprost—PTGER3—kidney—kidney cancer	0.00453	0.158	CbGeAlD
Bimatoprost—AKR1C3—Vinblastine—Vincristine—kidney cancer	0.00386	0.446	CbGdCrCtD
Bimatoprost—AKR1C3—nephron tubule—kidney cancer	0.00335	0.117	CbGeAlD
Bimatoprost—AKR1C3—cortex of kidney—kidney cancer	0.00287	0.1	CbGeAlD
Bimatoprost—AKR1C3—cardiac atrium—kidney cancer	0.00273	0.0951	CbGeAlD
Bimatoprost—Upper respiratory tract infection—Paclitaxel—kidney cancer	0.00053	0.00153	CcSEcCtD
Bimatoprost—Cough increased—Doxorubicin—kidney cancer	0.000525	0.00152	CcSEcCtD
Bimatoprost—Asthenia—Pazopanib—kidney cancer	0.000525	0.00152	CcSEcCtD
Bimatoprost—Insomnia—Everolimus—kidney cancer	0.000523	0.00151	CcSEcCtD
Bimatoprost—Lacrimation increased—Doxorubicin—kidney cancer	0.000522	0.00151	CcSEcCtD
Bimatoprost—Angiopathy—Vincristine—kidney cancer	0.000521	0.00151	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—kidney cancer	0.00052	0.0015	CcSEcCtD
Bimatoprost—Mediastinal disorder—Vincristine—kidney cancer	0.000518	0.0015	CcSEcCtD
Bimatoprost—Pruritus—Pazopanib—kidney cancer	0.000518	0.0015	CcSEcCtD
Bimatoprost—Cough—Sunitinib—kidney cancer	0.000516	0.00149	CcSEcCtD
Bimatoprost—Dyspnoea—Everolimus—kidney cancer	0.000515	0.00149	CcSEcCtD
Bimatoprost—Somnolence—Everolimus—kidney cancer	0.000514	0.00149	CcSEcCtD
Bimatoprost—Dizziness—Temsirolimus—kidney cancer	0.000514	0.00149	CcSEcCtD
Bimatoprost—Dry mouth—Sorafenib—kidney cancer	0.000512	0.00148	CcSEcCtD
Bimatoprost—Hypertension—Sunitinib—kidney cancer	0.000511	0.00148	CcSEcCtD
Bimatoprost—Dyspepsia—Everolimus—kidney cancer	0.000509	0.00147	CcSEcCtD
Bimatoprost—Depression—Paclitaxel—kidney cancer	0.000507	0.00147	CcSEcCtD
Bimatoprost—Insomnia—Erlotinib—kidney cancer	0.000504	0.00146	CcSEcCtD
Bimatoprost—Chest pain—Sunitinib—kidney cancer	0.000503	0.00146	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—kidney cancer	0.0005	0.00145	CcSEcCtD
Bimatoprost—Liver function test abnormal—Capecitabine—kidney cancer	0.0005	0.00145	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Everolimus—kidney cancer	0.000499	0.00144	CcSEcCtD
Bimatoprost—Infection—Sorafenib—kidney cancer	0.000498	0.00144	CcSEcCtD
Bimatoprost—Dyspnoea—Erlotinib—kidney cancer	0.000497	0.00144	CcSEcCtD
Bimatoprost—Dry skin—Capecitabine—kidney cancer	0.000496	0.00144	CcSEcCtD
Bimatoprost—Pain—Vinblastine—kidney cancer	0.000496	0.00144	CcSEcCtD
Bimatoprost—Inflammation—Doxorubicin—kidney cancer	0.000496	0.00144	CcSEcCtD
Bimatoprost—Angiopathy—Gemcitabine—kidney cancer	0.000495	0.00143	CcSEcCtD
Bimatoprost—Pain—Everolimus—kidney cancer	0.000494	0.00143	CcSEcCtD
Bimatoprost—Dry mouth—Sunitinib—kidney cancer	0.000492	0.00143	CcSEcCtD
Bimatoprost—Nervous system disorder—Sorafenib—kidney cancer	0.000492	0.00142	CcSEcCtD
Bimatoprost—Mediastinal disorder—Gemcitabine—kidney cancer	0.000491	0.00142	CcSEcCtD
Bimatoprost—Dyspepsia—Erlotinib—kidney cancer	0.000491	0.00142	CcSEcCtD
Bimatoprost—Rash—Temsirolimus—kidney cancer	0.00049	0.00142	CcSEcCtD
Bimatoprost—Dermatitis—Temsirolimus—kidney cancer	0.000489	0.00142	CcSEcCtD
Bimatoprost—Skin disorder—Sorafenib—kidney cancer	0.000487	0.00141	CcSEcCtD
Bimatoprost—Headache—Temsirolimus—kidney cancer	0.000487	0.00141	CcSEcCtD
Bimatoprost—Nasopharyngitis—Capecitabine—kidney cancer	0.000484	0.0014	CcSEcCtD
Bimatoprost—Dizziness—Pazopanib—kidney cancer	0.000484	0.0014	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Erlotinib—kidney cancer	0.000481	0.00139	CcSEcCtD
Bimatoprost—Infection—Sunitinib—kidney cancer	0.000479	0.00139	CcSEcCtD
Bimatoprost—Sinusitis—Paclitaxel—kidney cancer	0.000477	0.00138	CcSEcCtD
Bimatoprost—Pain—Erlotinib—kidney cancer	0.000477	0.00138	CcSEcCtD
Bimatoprost—Erythema—Gemcitabine—kidney cancer	0.000474	0.00137	CcSEcCtD
Bimatoprost—Nervous system disorder—Sunitinib—kidney cancer	0.000473	0.00137	CcSEcCtD
Bimatoprost—Cystitis noninfective—Doxorubicin—kidney cancer	0.00047	0.00136	CcSEcCtD
Bimatoprost—Skin disorder—Sunitinib—kidney cancer	0.000469	0.00136	CcSEcCtD
Bimatoprost—Asthma—Capecitabine—kidney cancer	0.000468	0.00135	CcSEcCtD
Bimatoprost—Cystitis—Doxorubicin—kidney cancer	0.000464	0.00134	CcSEcCtD
Bimatoprost—Rash—Pazopanib—kidney cancer	0.000461	0.00134	CcSEcCtD
Bimatoprost—Nausea—Temsirolimus—kidney cancer	0.000461	0.00134	CcSEcCtD
Bimatoprost—Dermatitis—Pazopanib—kidney cancer	0.000461	0.00133	CcSEcCtD
Bimatoprost—Headache—Pazopanib—kidney cancer	0.000458	0.00133	CcSEcCtD
Bimatoprost—Rhinitis—Paclitaxel—kidney cancer	0.000458	0.00132	CcSEcCtD
Bimatoprost—Infection—Dactinomycin—kidney cancer	0.000454	0.00131	CcSEcCtD
Bimatoprost—Pharyngitis—Paclitaxel—kidney cancer	0.000453	0.00131	CcSEcCtD
Bimatoprost—Bronchitis—Capecitabine—kidney cancer	0.00045	0.0013	CcSEcCtD
Bimatoprost—Oedema peripheral—Paclitaxel—kidney cancer	0.00045	0.0013	CcSEcCtD
Bimatoprost—Vertigo—Vincristine—kidney cancer	0.000449	0.0013	CcSEcCtD
Bimatoprost—Connective tissue disorder—Paclitaxel—kidney cancer	0.000448	0.0013	CcSEcCtD
Bimatoprost—Dyspnoea—Sorafenib—kidney cancer	0.000447	0.00129	CcSEcCtD
Bimatoprost—Dry eye—Doxorubicin—kidney cancer	0.000444	0.00129	CcSEcCtD
Bimatoprost—Dyspepsia—Sorafenib—kidney cancer	0.000442	0.00128	CcSEcCtD
Bimatoprost—Visual impairment—Paclitaxel—kidney cancer	0.00044	0.00127	CcSEcCtD
Bimatoprost—Insomnia—Sunitinib—kidney cancer	0.000437	0.00126	CcSEcCtD
Bimatoprost—Upper respiratory tract infection—Capecitabine—kidney cancer	0.000435	0.00126	CcSEcCtD
Bimatoprost—Nausea—Pazopanib—kidney cancer	0.000435	0.00126	CcSEcCtD
Bimatoprost—Bladder pain—Doxorubicin—kidney cancer	0.000435	0.00126	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000433	0.00125	CcSEcCtD
Bimatoprost—Hypertension—Vincristine—kidney cancer	0.000432	0.00125	CcSEcCtD
Bimatoprost—Dyspnoea—Sunitinib—kidney cancer	0.00043	0.00125	CcSEcCtD
Bimatoprost—Pain—Sorafenib—kidney cancer	0.000429	0.00124	CcSEcCtD
Bimatoprost—Eye disorder—Paclitaxel—kidney cancer	0.000426	0.00124	CcSEcCtD
Bimatoprost—Dyspepsia—Sunitinib—kidney cancer	0.000425	0.00123	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000417	0.00121	CcSEcCtD
Bimatoprost—Asthenia—Vinblastine—kidney cancer	0.000416	0.00121	CcSEcCtD
Bimatoprost—Depression—Capecitabine—kidney cancer	0.000416	0.0012	CcSEcCtD
Bimatoprost—Asthenia—Everolimus—kidney cancer	0.000415	0.0012	CcSEcCtD
Bimatoprost—Cough—Gemcitabine—kidney cancer	0.000414	0.0012	CcSEcCtD
Bimatoprost—Angiopathy—Paclitaxel—kidney cancer	0.000414	0.0012	CcSEcCtD
Bimatoprost—Pain—Sunitinib—kidney cancer	0.000413	0.0012	CcSEcCtD
Bimatoprost—Mediastinal disorder—Paclitaxel—kidney cancer	0.000411	0.00119	CcSEcCtD
Bimatoprost—Hypertension—Gemcitabine—kidney cancer	0.00041	0.00119	CcSEcCtD
Bimatoprost—Pruritus—Everolimus—kidney cancer	0.000409	0.00118	CcSEcCtD
Bimatoprost—Infection—Vincristine—kidney cancer	0.000406	0.00117	CcSEcCtD
Bimatoprost—Chest pain—Gemcitabine—kidney cancer	0.000404	0.00117	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.000401	0.00116	CcSEcCtD
Bimatoprost—Nervous system disorder—Vincristine—kidney cancer	0.0004	0.00116	CcSEcCtD
Bimatoprost—Asthenia—Erlotinib—kidney cancer	0.0004	0.00116	CcSEcCtD
Bimatoprost—Erythema—Paclitaxel—kidney cancer	0.000397	0.00115	CcSEcCtD
Bimatoprost—Pruritus—Erlotinib—kidney cancer	0.000394	0.00114	CcSEcCtD
Bimatoprost—Pain—Dactinomycin—kidney cancer	0.000391	0.00113	CcSEcCtD
Bimatoprost—Tension—Paclitaxel—kidney cancer	0.00039	0.00113	CcSEcCtD
Bimatoprost—Eye pain—Doxorubicin—kidney cancer	0.000387	0.00112	CcSEcCtD
Bimatoprost—Nervousness—Paclitaxel—kidney cancer	0.000386	0.00112	CcSEcCtD
Bimatoprost—Infection—Gemcitabine—kidney cancer	0.000385	0.00111	CcSEcCtD
Bimatoprost—Dizziness—Vinblastine—kidney cancer	0.000384	0.00111	CcSEcCtD
Bimatoprost—Dizziness—Everolimus—kidney cancer	0.000382	0.00111	CcSEcCtD
Bimatoprost—Nervous system disorder—Gemcitabine—kidney cancer	0.00038	0.0011	CcSEcCtD
Bimatoprost—Skin disorder—Gemcitabine—kidney cancer	0.000376	0.00109	CcSEcCtD
Bimatoprost—Rhinitis—Capecitabine—kidney cancer	0.000375	0.00109	CcSEcCtD
Bimatoprost—Vision blurred—Paclitaxel—kidney cancer	0.000374	0.00108	CcSEcCtD
Bimatoprost—Pharyngitis—Capecitabine—kidney cancer	0.000372	0.00108	CcSEcCtD
Bimatoprost—Insomnia—Vincristine—kidney cancer	0.000369	0.00107	CcSEcCtD
Bimatoprost—Oedema peripheral—Capecitabine—kidney cancer	0.000369	0.00107	CcSEcCtD
Bimatoprost—Dizziness—Erlotinib—kidney cancer	0.000369	0.00107	CcSEcCtD
Bimatoprost—Connective tissue disorder—Capecitabine—kidney cancer	0.000368	0.00107	CcSEcCtD
Bimatoprost—Rash—Everolimus—kidney cancer	0.000364	0.00106	CcSEcCtD
Bimatoprost—Dermatitis—Everolimus—kidney cancer	0.000364	0.00105	CcSEcCtD
Bimatoprost—Headache—Vinblastine—kidney cancer	0.000363	0.00105	CcSEcCtD
Bimatoprost—Headache—Everolimus—kidney cancer	0.000362	0.00105	CcSEcCtD
Bimatoprost—Visual impairment—Capecitabine—kidney cancer	0.000361	0.00105	CcSEcCtD
Bimatoprost—Asthenia—Sorafenib—kidney cancer	0.00036	0.00104	CcSEcCtD
Bimatoprost—Vertigo—Paclitaxel—kidney cancer	0.000357	0.00103	CcSEcCtD
Bimatoprost—Pruritus—Sorafenib—kidney cancer	0.000355	0.00103	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Vincristine—kidney cancer	0.000352	0.00102	CcSEcCtD
Bimatoprost—Rash—Erlotinib—kidney cancer	0.000352	0.00102	CcSEcCtD
Bimatoprost—Dermatitis—Erlotinib—kidney cancer	0.000351	0.00102	CcSEcCtD
Bimatoprost—Palpitations—Paclitaxel—kidney cancer	0.000351	0.00102	CcSEcCtD
Bimatoprost—Insomnia—Gemcitabine—kidney cancer	0.00035	0.00101	CcSEcCtD
Bimatoprost—Eye disorder—Capecitabine—kidney cancer	0.00035	0.00101	CcSEcCtD
Bimatoprost—Headache—Erlotinib—kidney cancer	0.000349	0.00101	CcSEcCtD
Bimatoprost—Pain—Vincristine—kidney cancer	0.000349	0.00101	CcSEcCtD
Bimatoprost—Diplopia—Doxorubicin—kidney cancer	0.000349	0.00101	CcSEcCtD
Bimatoprost—Cough—Paclitaxel—kidney cancer	0.000347	0.001	CcSEcCtD
Bimatoprost—Asthenia—Sunitinib—kidney cancer	0.000346	0.001	CcSEcCtD
Bimatoprost—Dyspnoea—Gemcitabine—kidney cancer	0.000345	0.001	CcSEcCtD
Bimatoprost—Nausea—Vinblastine—kidney cancer	0.000345	0.000998	CcSEcCtD
Bimatoprost—Somnolence—Gemcitabine—kidney cancer	0.000344	0.000997	CcSEcCtD
Bimatoprost—Nausea—Everolimus—kidney cancer	0.000343	0.000994	CcSEcCtD
Bimatoprost—Hypertension—Paclitaxel—kidney cancer	0.000343	0.000993	CcSEcCtD
Bimatoprost—Pruritus—Sunitinib—kidney cancer	0.000341	0.000989	CcSEcCtD
Bimatoprost—Angiopathy—Capecitabine—kidney cancer	0.00034	0.000984	CcSEcCtD
Bimatoprost—Chest pain—Paclitaxel—kidney cancer	0.000338	0.000979	CcSEcCtD
Bimatoprost—Mediastinal disorder—Capecitabine—kidney cancer	0.000338	0.000977	CcSEcCtD
Bimatoprost—Anxiety—Paclitaxel—kidney cancer	0.000337	0.000976	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000336	0.000973	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000334	0.000968	CcSEcCtD
Bimatoprost—Dizziness—Sorafenib—kidney cancer	0.000332	0.00096	CcSEcCtD
Bimatoprost—Pain—Gemcitabine—kidney cancer	0.000331	0.000959	CcSEcCtD
Bimatoprost—Nausea—Erlotinib—kidney cancer	0.000331	0.000959	CcSEcCtD
Bimatoprost—Dry mouth—Paclitaxel—kidney cancer	0.000331	0.000958	CcSEcCtD
Bimatoprost—Asthenia—Dactinomycin—kidney cancer	0.000328	0.000949	CcSEcCtD
Bimatoprost—Erythema—Capecitabine—kidney cancer	0.000326	0.000944	CcSEcCtD
Bimatoprost—Liver function test abnormal—Doxorubicin—kidney cancer	0.000322	0.000933	CcSEcCtD
Bimatoprost—Infection—Paclitaxel—kidney cancer	0.000322	0.000933	CcSEcCtD
Bimatoprost—Dry skin—Doxorubicin—kidney cancer	0.00032	0.000926	CcSEcCtD
Bimatoprost—Dizziness—Sunitinib—kidney cancer	0.000319	0.000924	CcSEcCtD
Bimatoprost—Nervous system disorder—Paclitaxel—kidney cancer	0.000318	0.000921	CcSEcCtD
Bimatoprost—Rash—Sorafenib—kidney cancer	0.000316	0.000916	CcSEcCtD
Bimatoprost—Dermatitis—Sorafenib—kidney cancer	0.000316	0.000915	CcSEcCtD
Bimatoprost—Skin disorder—Paclitaxel—kidney cancer	0.000315	0.000912	CcSEcCtD
Bimatoprost—Headache—Sorafenib—kidney cancer	0.000314	0.00091	CcSEcCtD
Bimatoprost—Nasopharyngitis—Doxorubicin—kidney cancer	0.000312	0.000904	CcSEcCtD
Bimatoprost—Vision blurred—Capecitabine—kidney cancer	0.000307	0.00089	CcSEcCtD
Bimatoprost—Rash—Sunitinib—kidney cancer	0.000304	0.000881	CcSEcCtD
Bimatoprost—Dermatitis—Sunitinib—kidney cancer	0.000304	0.00088	CcSEcCtD
Bimatoprost—Headache—Sunitinib—kidney cancer	0.000302	0.000876	CcSEcCtD
Bimatoprost—Asthma—Doxorubicin—kidney cancer	0.000302	0.000873	CcSEcCtD
Bimatoprost—Nausea—Sorafenib—kidney cancer	0.000298	0.000863	CcSEcCtD
Bimatoprost—Insomnia—Paclitaxel—kidney cancer	0.000293	0.000849	CcSEcCtD
Bimatoprost—Vertigo—Capecitabine—kidney cancer	0.000293	0.000848	CcSEcCtD
Bimatoprost—Asthenia—Vincristine—kidney cancer	0.000293	0.000848	CcSEcCtD
Bimatoprost—Bronchitis—Doxorubicin—kidney cancer	0.00029	0.00084	CcSEcCtD
Bimatoprost—Dyspnoea—Paclitaxel—kidney cancer	0.000289	0.000837	CcSEcCtD
Bimatoprost—Somnolence—Paclitaxel—kidney cancer	0.000288	0.000835	CcSEcCtD
Bimatoprost—Palpitations—Capecitabine—kidney cancer	0.000288	0.000834	CcSEcCtD
Bimatoprost—Rash—Dactinomycin—kidney cancer	0.000288	0.000834	CcSEcCtD
Bimatoprost—Nausea—Sunitinib—kidney cancer	0.000287	0.00083	CcSEcCtD
Bimatoprost—Dyspepsia—Paclitaxel—kidney cancer	0.000285	0.000826	CcSEcCtD
Bimatoprost—Cough—Capecitabine—kidney cancer	0.000284	0.000824	CcSEcCtD
Bimatoprost—Hypertension—Capecitabine—kidney cancer	0.000281	0.000815	CcSEcCtD
Bimatoprost—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.00028	0.000812	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.00028	0.000811	CcSEcCtD
Bimatoprost—Asthenia—Gemcitabine—kidney cancer	0.000278	0.000805	CcSEcCtD
Bimatoprost—Chest pain—Capecitabine—kidney cancer	0.000278	0.000804	CcSEcCtD
Bimatoprost—Pain—Paclitaxel—kidney cancer	0.000277	0.000803	CcSEcCtD
Bimatoprost—Anxiety—Capecitabine—kidney cancer	0.000277	0.000801	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000276	0.000798	CcSEcCtD
Bimatoprost—Pruritus—Gemcitabine—kidney cancer	0.000274	0.000793	CcSEcCtD
Bimatoprost—Dry mouth—Capecitabine—kidney cancer	0.000271	0.000786	CcSEcCtD
Bimatoprost—Nausea—Dactinomycin—kidney cancer	0.000271	0.000786	CcSEcCtD
Bimatoprost—Dizziness—Vincristine—kidney cancer	0.00027	0.000782	CcSEcCtD
Bimatoprost—Infection—Capecitabine—kidney cancer	0.000264	0.000765	CcSEcCtD
Bimatoprost—Nervous system disorder—Capecitabine—kidney cancer	0.000261	0.000756	CcSEcCtD
Bimatoprost—Skin disorder—Capecitabine—kidney cancer	0.000258	0.000748	CcSEcCtD
Bimatoprost—Rash—Vincristine—kidney cancer	0.000257	0.000745	CcSEcCtD
Bimatoprost—Dermatitis—Vincristine—kidney cancer	0.000257	0.000745	CcSEcCtD
Bimatoprost—Headache—Vincristine—kidney cancer	0.000256	0.000741	CcSEcCtD
Bimatoprost—Sinusitis—Doxorubicin—kidney cancer	0.000252	0.000731	CcSEcCtD
Bimatoprost—Rash—Gemcitabine—kidney cancer	0.000244	0.000707	CcSEcCtD
Bimatoprost—Dermatitis—Gemcitabine—kidney cancer	0.000244	0.000706	CcSEcCtD
Bimatoprost—Headache—Gemcitabine—kidney cancer	0.000243	0.000703	CcSEcCtD
Bimatoprost—Nausea—Vincristine—kidney cancer	0.000242	0.000702	CcSEcCtD
Bimatoprost—Rhinitis—Doxorubicin—kidney cancer	0.000242	0.000701	CcSEcCtD
Bimatoprost—Insomnia—Capecitabine—kidney cancer	0.000241	0.000697	CcSEcCtD
Bimatoprost—Pharyngitis—Doxorubicin—kidney cancer	0.00024	0.000694	CcSEcCtD
Bimatoprost—Oedema peripheral—Doxorubicin—kidney cancer	0.000238	0.000689	CcSEcCtD
Bimatoprost—Connective tissue disorder—Doxorubicin—kidney cancer	0.000237	0.000687	CcSEcCtD
Bimatoprost—Dyspnoea—Capecitabine—kidney cancer	0.000237	0.000687	CcSEcCtD
Bimatoprost—Dyspepsia—Capecitabine—kidney cancer	0.000234	0.000678	CcSEcCtD
Bimatoprost—Visual impairment—Doxorubicin—kidney cancer	0.000233	0.000674	CcSEcCtD
Bimatoprost—Asthenia—Paclitaxel—kidney cancer	0.000233	0.000674	CcSEcCtD
Bimatoprost—Nausea—Gemcitabine—kidney cancer	0.00023	0.000666	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Capecitabine—kidney cancer	0.00023	0.000665	CcSEcCtD
Bimatoprost—Pruritus—Paclitaxel—kidney cancer	0.000229	0.000664	CcSEcCtD
Bimatoprost—Pain—Capecitabine—kidney cancer	0.000228	0.000659	CcSEcCtD
Bimatoprost—Eye disorder—Doxorubicin—kidney cancer	0.000226	0.000653	CcSEcCtD
Bimatoprost—Angiopathy—Doxorubicin—kidney cancer	0.000219	0.000634	CcSEcCtD
Bimatoprost—Mediastinal disorder—Doxorubicin—kidney cancer	0.000218	0.00063	CcSEcCtD
Bimatoprost—Dizziness—Paclitaxel—kidney cancer	0.000214	0.000621	CcSEcCtD
Bimatoprost—Erythema—Doxorubicin—kidney cancer	0.00021	0.000609	CcSEcCtD
Bimatoprost—Tension—Doxorubicin—kidney cancer	0.000206	0.000597	CcSEcCtD
Bimatoprost—Rash—Paclitaxel—kidney cancer	0.000204	0.000592	CcSEcCtD
Bimatoprost—Dermatitis—Paclitaxel—kidney cancer	0.000204	0.000591	CcSEcCtD
Bimatoprost—Nervousness—Doxorubicin—kidney cancer	0.000204	0.000591	CcSEcCtD
Bimatoprost—Headache—Paclitaxel—kidney cancer	0.000203	0.000588	CcSEcCtD
Bimatoprost—Vision blurred—Doxorubicin—kidney cancer	0.000198	0.000574	CcSEcCtD
Bimatoprost—Nausea—Paclitaxel—kidney cancer	0.000193	0.000558	CcSEcCtD
Bimatoprost—Asthenia—Capecitabine—kidney cancer	0.000191	0.000553	CcSEcCtD
Bimatoprost—Vertigo—Doxorubicin—kidney cancer	0.000189	0.000547	CcSEcCtD
Bimatoprost—Pruritus—Capecitabine—kidney cancer	0.000188	0.000545	CcSEcCtD
Bimatoprost—Palpitations—Doxorubicin—kidney cancer	0.000186	0.000538	CcSEcCtD
Bimatoprost—Cough—Doxorubicin—kidney cancer	0.000183	0.000531	CcSEcCtD
Bimatoprost—Hypertension—Doxorubicin—kidney cancer	0.000181	0.000525	CcSEcCtD
Bimatoprost—Chest pain—Doxorubicin—kidney cancer	0.000179	0.000518	CcSEcCtD
Bimatoprost—Anxiety—Doxorubicin—kidney cancer	0.000178	0.000516	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000178	0.000515	CcSEcCtD
Bimatoprost—Dizziness—Capecitabine—kidney cancer	0.000176	0.00051	CcSEcCtD
Bimatoprost—Dry mouth—Doxorubicin—kidney cancer	0.000175	0.000507	CcSEcCtD
Bimatoprost—AKR1C3—Metabolism—CA9—kidney cancer	0.000172	0.00117	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—SFRP2—kidney cancer	0.000171	0.00117	CbGpPWpGaD
Bimatoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—kidney cancer	0.000171	0.00117	CbGpPWpGaD
Bimatoprost—Infection—Doxorubicin—kidney cancer	0.00017	0.000493	CcSEcCtD
Bimatoprost—PTGFR—Signaling by GPCR—ANXA1—kidney cancer	0.00017	0.00116	CbGpPWpGaD
Bimatoprost—Nervous system disorder—Doxorubicin—kidney cancer	0.000168	0.000487	CcSEcCtD
Bimatoprost—Rash—Capecitabine—kidney cancer	0.000168	0.000486	CcSEcCtD
Bimatoprost—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—kidney cancer	0.000168	0.00114	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	0.000168	0.00114	CbGpPWpGaD
Bimatoprost—Dermatitis—Capecitabine—kidney cancer	0.000168	0.000485	CcSEcCtD
Bimatoprost—Headache—Capecitabine—kidney cancer	0.000167	0.000483	CcSEcCtD
Bimatoprost—PTGER1—Signaling by GPCR—ANXA1—kidney cancer	0.000167	0.00113	CbGpPWpGaD
Bimatoprost—Skin disorder—Doxorubicin—kidney cancer	0.000167	0.000482	CcSEcCtD
Bimatoprost—AKR1C3—Signaling Pathways—SFRP2—kidney cancer	0.000165	0.00113	CbGpPWpGaD
Bimatoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—kidney cancer	0.000163	0.00111	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR ligand binding—POMC—kidney cancer	0.000163	0.00111	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—ITPR2—kidney cancer	0.000162	0.0011	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—ITPR2—kidney cancer	0.000161	0.00109	CbGpPWpGaD
Bimatoprost—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—kidney cancer	0.00016	0.00109	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR ligand binding—POMC—kidney cancer	0.000159	0.00108	CbGpPWpGaD
Bimatoprost—PTGFR—G alpha (q) signalling events—PIK3CA—kidney cancer	0.000158	0.00108	CbGpPWpGaD
Bimatoprost—Nausea—Capecitabine—kidney cancer	0.000158	0.000458	CcSEcCtD
Bimatoprost—Insomnia—Doxorubicin—kidney cancer	0.000155	0.000449	CcSEcCtD
Bimatoprost—PTGER1—G alpha (q) signalling events—PIK3CA—kidney cancer	0.000155	0.00105	CbGpPWpGaD
Bimatoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—kidney cancer	0.000154	0.00105	CbGpPWpGaD
Bimatoprost—Dyspnoea—Doxorubicin—kidney cancer	0.000153	0.000443	CcSEcCtD
Bimatoprost—Somnolence—Doxorubicin—kidney cancer	0.000152	0.000442	CcSEcCtD
Bimatoprost—Dyspepsia—Doxorubicin—kidney cancer	0.000151	0.000437	CcSEcCtD
Bimatoprost—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—kidney cancer	0.000151	0.00103	CbGpPWpGaD
Bimatoprost—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000148	0.000429	CcSEcCtD
Bimatoprost—Pain—Doxorubicin—kidney cancer	0.000147	0.000425	CcSEcCtD
Bimatoprost—AKR1C3—Metabolism—CRABP1—kidney cancer	0.000146	0.000993	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CTNNA1—kidney cancer	0.000146	0.000991	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—EIF4EBP1—kidney cancer	0.000145	0.000985	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—HSPB1—kidney cancer	0.000145	0.000985	CbGpPWpGaD
Bimatoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—kidney cancer	0.000141	0.000963	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—AKAP13—kidney cancer	0.000141	0.000961	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CASP2—kidney cancer	0.000141	0.000961	CbGpPWpGaD
Bimatoprost—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—kidney cancer	0.000138	0.000943	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—AKAP13—kidney cancer	0.000138	0.000941	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CASP2—kidney cancer	0.000138	0.000941	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PSMD7—kidney cancer	0.000136	0.000923	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—ITPR2—kidney cancer	0.000136	0.000923	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—TSC1—kidney cancer	0.000135	0.000916	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—ANXA1—kidney cancer	0.000135	0.000916	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PSMD7—kidney cancer	0.000135	0.000916	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—AKAP13—kidney cancer	0.000133	0.000908	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CASP2—kidney cancer	0.000133	0.000908	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—FLT1—kidney cancer	0.00013	0.000887	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—GRB7—kidney cancer	0.000129	0.000879	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—GRB7—kidney cancer	0.000126	0.00086	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—POMC—kidney cancer	0.000125	0.000851	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—GSTT1—kidney cancer	0.000124	0.000842	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—ACHE—kidney cancer	0.000124	0.000842	CbGpPWpGaD
Bimatoprost—Asthenia—Doxorubicin—kidney cancer	0.000123	0.000356	CcSEcCtD
Bimatoprost—PTGER3—GPCR downstream signaling—POMC—kidney cancer	0.000123	0.000836	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—SLC2A1—kidney cancer	0.000123	0.000835	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—GRB7—kidney cancer	0.000122	0.00083	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—JUNB—kidney cancer	0.000122	0.000829	CbGpPWpGaD
Bimatoprost—Pruritus—Doxorubicin—kidney cancer	0.000121	0.000351	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—JUNB—kidney cancer	0.000121	0.000822	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PAK1—kidney cancer	0.000121	0.000822	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—ITPR2—kidney cancer	0.00012	0.000817	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—ITPR2—kidney cancer	0.000117	0.0008	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—SCARB1—kidney cancer	0.000117	0.000797	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PTGS1—kidney cancer	0.000116	0.000789	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PSMD7—kidney cancer	0.000114	0.000773	CbGpPWpGaD
Bimatoprost—Dizziness—Doxorubicin—kidney cancer	0.000113	0.000328	CcSEcCtD
Bimatoprost—AKR1C3—Signaling Pathways—ITPR2—kidney cancer	0.000113	0.000772	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—POMC—kidney cancer	0.000112	0.000759	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CTNNA1—kidney cancer	0.000109	0.000741	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—HSPB1—kidney cancer	0.000108	0.000737	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—EIF4EBP1—kidney cancer	0.000108	0.000737	CbGpPWpGaD
Bimatoprost—Rash—Doxorubicin—kidney cancer	0.000108	0.000313	CcSEcCtD
Bimatoprost—Dermatitis—Doxorubicin—kidney cancer	0.000108	0.000313	CcSEcCtD
Bimatoprost—AKR1C3—Metabolism—BCHE—kidney cancer	0.000108	0.000733	CbGpPWpGaD
Bimatoprost—Headache—Doxorubicin—kidney cancer	0.000107	0.000311	CcSEcCtD
Bimatoprost—PTGER1—Signaling Pathways—CTNNA1—kidney cancer	0.000107	0.000725	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—SLC5A5—kidney cancer	0.000106	0.000724	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—EIF4EBP1—kidney cancer	0.000106	0.000721	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—HSPB1—kidney cancer	0.000106	0.000721	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CTNNA1—kidney cancer	0.000103	0.0007	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—SLC2A1—kidney cancer	0.000103	0.000699	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—HSPB1—kidney cancer	0.000102	0.000696	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—EIF4EBP1—kidney cancer	0.000102	0.000696	CbGpPWpGaD
Bimatoprost—Nausea—Doxorubicin—kidney cancer	0.000102	0.000295	CcSEcCtD
Bimatoprost—PTGFR—Signaling Pathways—ANXA1—kidney cancer	0.000101	0.000685	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PSMD7—kidney cancer	0.000101	0.000685	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—TSC1—kidney cancer	0.000101	0.000685	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	9.97e-05	0.000679	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—CDKN2B—kidney cancer	9.91e-05	0.000675	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—IGF2—kidney cancer	9.87e-05	0.000672	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PSMD7—kidney cancer	9.85e-05	0.00067	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—TSC1—kidney cancer	9.85e-05	0.00067	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—ANXA1—kidney cancer	9.85e-05	0.00067	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CDKN2B—kidney cancer	9.83e-05	0.000669	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—FLT1—kidney cancer	9.74e-05	0.000663	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—IGF1R—kidney cancer	9.55e-05	0.00065	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—FLT1—kidney cancer	9.54e-05	0.000649	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PSMD7—kidney cancer	9.5e-05	0.000647	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—TSC1—kidney cancer	9.5e-05	0.000647	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—ANXA1—kidney cancer	9.5e-05	0.000647	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—FLT1—kidney cancer	9.2e-05	0.000626	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—RAF1—kidney cancer	9.2e-05	0.000626	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—POMC—kidney cancer	9.19e-05	0.000625	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—IL2—kidney cancer	9.08e-05	0.000618	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—JUNB—kidney cancer	9.03e-05	0.000615	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PAK1—kidney cancer	9.03e-05	0.000615	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—POMC—kidney cancer	8.99e-05	0.000612	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PAK1—kidney cancer	8.84e-05	0.000602	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—JUNB—kidney cancer	8.84e-05	0.000602	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	8.69e-05	0.000592	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—GSTP1—kidney cancer	8.57e-05	0.000583	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—JUNB—kidney cancer	8.53e-05	0.000581	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PAK1—kidney cancer	8.53e-05	0.000581	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—POMC—kidney cancer	8.34e-05	0.000568	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—IL2—kidney cancer	8.25e-05	0.000561	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—POMC—kidney cancer	8.17e-05	0.000556	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—ABCB1—kidney cancer	8.11e-05	0.000552	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—HIF1A—kidney cancer	7.93e-05	0.00054	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—TSC2—kidney cancer	7.91e-05	0.000538	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—GSTM1—kidney cancer	7.87e-05	0.000536	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—HIF1A—kidney cancer	7.86e-05	0.000535	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—TSC2—kidney cancer	7.84e-05	0.000534	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—KDR—kidney cancer	7.52e-05	0.000512	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—CYP1A1—kidney cancer	7.47e-05	0.000508	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—IGF2—kidney cancer	7.38e-05	0.000503	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CDKN2B—kidney cancer	7.35e-05	0.0005	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—IGF2—kidney cancer	7.23e-05	0.000492	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CDKN2B—kidney cancer	7.2e-05	0.00049	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—IGF1R—kidney cancer	7.14e-05	0.000486	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—IGF1R—kidney cancer	6.99e-05	0.000476	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—KIT—kidney cancer	6.98e-05	0.000475	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—APC—kidney cancer	6.98e-05	0.000475	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—IGF2—kidney cancer	6.97e-05	0.000475	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CDKN2B—kidney cancer	6.94e-05	0.000473	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—APC—kidney cancer	6.92e-05	0.000471	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—KIT—kidney cancer	6.92e-05	0.000471	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—RAF1—kidney cancer	6.88e-05	0.000468	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—IL2—kidney cancer	6.79e-05	0.000462	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—IGF1R—kidney cancer	6.74e-05	0.000459	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—RAF1—kidney cancer	6.73e-05	0.000458	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—IL2—kidney cancer	6.65e-05	0.000453	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—MAPK3—kidney cancer	6.63e-05	0.000451	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—POMC—kidney cancer	6.59e-05	0.000449	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—BRAF—kidney cancer	6.56e-05	0.000447	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—BRAF—kidney cancer	6.51e-05	0.000443	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—MAPK1—kidney cancer	6.31e-05	0.00043	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—IL2—kidney cancer	6.17e-05	0.00042	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	6.13e-05	0.000418	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—IL2—kidney cancer	6.04e-05	0.000411	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—PIK3CA—kidney cancer	6.03e-05	0.00041	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—KRAS—kidney cancer	5.96e-05	0.000406	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—HIF1A—kidney cancer	5.88e-05	0.0004	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—TSC2—kidney cancer	5.86e-05	0.000399	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—HIF1A—kidney cancer	5.75e-05	0.000392	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—TSC2—kidney cancer	5.74e-05	0.000391	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—KDR—kidney cancer	5.62e-05	0.000383	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—POMC—kidney cancer	5.57e-05	0.000379	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—HIF1A—kidney cancer	5.55e-05	0.000378	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—TSC2—kidney cancer	5.54e-05	0.000377	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—KDR—kidney cancer	5.5e-05	0.000375	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—RAF1—kidney cancer	5.48e-05	0.000373	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—PIK3CA—kidney cancer	5.47e-05	0.000373	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—RAF1—kidney cancer	5.43e-05	0.00037	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—ERBB2—kidney cancer	5.42e-05	0.000369	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—RELA—kidney cancer	5.41e-05	0.000368	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—ERBB2—kidney cancer	5.38e-05	0.000366	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—MTOR—kidney cancer	5.35e-05	0.000364	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—CD4—kidney cancer	5.34e-05	0.000364	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—KDR—kidney cancer	5.31e-05	0.000361	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—MTOR—kidney cancer	5.31e-05	0.000361	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PTGS2—kidney cancer	5.3e-05	0.000361	CbGpPWpGaD
Bimatoprost—Tafluprost—PTGS2—kidney cancer	5.29e-05	1	CrCbGaD
Bimatoprost—PTGFR—Signaling Pathways—APC—kidney cancer	5.18e-05	0.000352	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—KIT—kidney cancer	5.18e-05	0.000352	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—APC—kidney cancer	5.07e-05	0.000345	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—KIT—kidney cancer	5.07e-05	0.000345	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—CDKN1B—kidney cancer	5.02e-05	0.000342	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CDKN1B—kidney cancer	4.98e-05	0.000339	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—MAPK3—kidney cancer	4.96e-05	0.000338	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—POMC—kidney cancer	4.93e-05	0.000335	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—APC—kidney cancer	4.89e-05	0.000333	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—KIT—kidney cancer	4.89e-05	0.000333	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—IL2—kidney cancer	4.87e-05	0.000332	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—BRAF—kidney cancer	4.87e-05	0.000331	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—MAPK3—kidney cancer	4.85e-05	0.00033	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—POMC—kidney cancer	4.82e-05	0.000328	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—BRAF—kidney cancer	4.76e-05	0.000324	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CCND1—kidney cancer	4.75e-05	0.000323	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—CTNNB1—kidney cancer	4.74e-05	0.000323	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—JUN—kidney cancer	4.74e-05	0.000323	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—MAPK1—kidney cancer	4.72e-05	0.000321	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CTNNB1—kidney cancer	4.7e-05	0.00032	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—POMC—kidney cancer	4.65e-05	0.000317	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PTEN—kidney cancer	4.62e-05	0.000315	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—MAPK1—kidney cancer	4.62e-05	0.000314	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—BRAF—kidney cancer	4.6e-05	0.000313	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PTEN—kidney cancer	4.58e-05	0.000312	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—PIK3CA—kidney cancer	4.51e-05	0.000307	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—KRAS—kidney cancer	4.46e-05	0.000303	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PTGS2—kidney cancer	4.44e-05	0.000302	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—PIK3CA—kidney cancer	4.41e-05	0.0003	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—KRAS—kidney cancer	4.36e-05	0.000297	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—VEGFA—kidney cancer	4.14e-05	0.000282	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—PIK3CA—kidney cancer	4.09e-05	0.000279	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—RAF1—kidney cancer	4.06e-05	0.000277	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—RELA—kidney cancer	4.05e-05	0.000275	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—ERBB2—kidney cancer	4.02e-05	0.000274	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—PIK3CA—kidney cancer	4.01e-05	0.000273	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—RAF1—kidney cancer	3.98e-05	0.000271	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—MTOR—kidney cancer	3.97e-05	0.00027	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—RELA—kidney cancer	3.96e-05	0.00027	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—MAPK3—kidney cancer	3.95e-05	0.000269	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—ERBB2—kidney cancer	3.93e-05	0.000268	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—MAPK3—kidney cancer	3.92e-05	0.000267	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—MTOR—kidney cancer	3.88e-05	0.000264	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PTEN—kidney cancer	3.87e-05	0.000264	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—MYC—kidney cancer	3.84e-05	0.000262	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—RAF1—kidney cancer	3.84e-05	0.000261	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—RELA—kidney cancer	3.82e-05	0.00026	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—MYC—kidney cancer	3.81e-05	0.000259	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—ERBB2—kidney cancer	3.8e-05	0.000258	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—MAPK1—kidney cancer	3.76e-05	0.000256	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—MTOR—kidney cancer	3.75e-05	0.000255	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—MAPK1—kidney cancer	3.73e-05	0.000254	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CDKN1B—kidney cancer	3.72e-05	0.000253	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CDKN1B—kidney cancer	3.64e-05	0.000248	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—IL2—kidney cancer	3.64e-05	0.000248	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—IL2—kidney cancer	3.57e-05	0.000243	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CCND1—kidney cancer	3.55e-05	0.000242	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—KRAS—kidney cancer	3.55e-05	0.000242	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—JUN—kidney cancer	3.54e-05	0.000241	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—KRAS—kidney cancer	3.52e-05	0.00024	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CTNNB1—kidney cancer	3.52e-05	0.000239	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CDKN1B—kidney cancer	3.52e-05	0.000239	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CCND1—kidney cancer	3.48e-05	0.000237	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—JUN—kidney cancer	3.47e-05	0.000236	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CTNNB1—kidney cancer	3.44e-05	0.000234	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—IL2—kidney cancer	3.44e-05	0.000234	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PTEN—kidney cancer	3.43e-05	0.000233	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PTEN—kidney cancer	3.36e-05	0.000228	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CCND1—kidney cancer	3.35e-05	0.000228	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—JUN—kidney cancer	3.35e-05	0.000228	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CTNNB1—kidney cancer	3.32e-05	0.000226	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PIK3CA—kidney cancer	3.26e-05	0.000222	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PTEN—kidney cancer	3.24e-05	0.00022	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PIK3CA—kidney cancer	3.23e-05	0.00022	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—TP53—kidney cancer	3.13e-05	0.000213	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—VEGFA—kidney cancer	3.1e-05	0.000211	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—VEGFA—kidney cancer	3.03e-05	0.000206	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—MAPK3—kidney cancer	2.93e-05	0.000199	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—VEGFA—kidney cancer	2.92e-05	0.000199	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—MAPK3—kidney cancer	2.87e-05	0.000195	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—MYC—kidney cancer	2.85e-05	0.000194	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—MYC—kidney cancer	2.79e-05	0.00019	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—MAPK1—kidney cancer	2.79e-05	0.00019	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—MAPK3—kidney cancer	2.77e-05	0.000188	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PIK3CA—kidney cancer	2.73e-05	0.000186	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—MAPK1—kidney cancer	2.73e-05	0.000186	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—MYC—kidney cancer	2.69e-05	0.000183	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—KRAS—kidney cancer	2.63e-05	0.000179	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—MAPK1—kidney cancer	2.63e-05	0.000179	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—KRAS—kidney cancer	2.58e-05	0.000175	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—KRAS—kidney cancer	2.49e-05	0.000169	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PIK3CA—kidney cancer	2.42e-05	0.000165	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PIK3CA—kidney cancer	2.37e-05	0.000161	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—TP53—kidney cancer	2.34e-05	0.000159	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—TP53—kidney cancer	2.29e-05	0.000156	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PIK3CA—kidney cancer	2.28e-05	0.000155	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—TP53—kidney cancer	2.21e-05	0.00015	CbGpPWpGaD
